Agios Pharmaceuticals Inc (STU:8AP)
€ 42 2.6 (6.6%) Market Cap: 2.40 Bil Enterprise Value: 1.91 Bil PE Ratio: 0 PB Ratio: 3.45 GF Score: 41/100

Agios Pharmaceuticals Inc Leadership Update Transcript

Jul 12, 2022 / 08:30PM GMT
Release Date Price: €23 (-9.45%)
Operator

Good afternoon, and welcome to the Agios Leadership Update Conference Call. (Operator Instructions) Please be advised that this call is being recorded at Agios' request. I would now like to turn the call over to Holly Manning, Senior Director of Investor Relations.

Holly Manning
Agios Pharmaceuticals, Inc. - Senior Director of IR

Good afternoon, everyone, and thank you for joining our investor webcast. With me on the call today are Jackie Fouse, Agios' current Chief Executive Officer; and Brian Goff, who will assume the role as CEO of Agios in August. We will hold a Q&A session with Jackie and Brian at the end of the call.

Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual events and results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in our most recent filings with the SEC and any other future filings that we may

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot